SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) today provided an update on the status of the company’s submissions to the Food and Drug Administration (FDA). BSD currently has two FDA submissions in progress, a premarket (PMA) submission for the BSD-2000 Hyperthermia System and a 510(k) premarket notification seeking FDA marketing clearance for the MicroThermX-100 Ablation System.
